Member Info for PM2022

Deadline this week: Barcelona also due.

Evaluation agreement with Hokkaido University

ValiRx Plc (AIM: VAL), a life science company focusing on early-stage cancer therapeutics and women's health, has entered into an evaluation agreement with Hokkaido University (Japan) to investigate a drug candidate for use in oncology.

Under the agreement, the Company will carry out a defined series of preclinical tests on the peptide drug candidate molecule over the next twelve months to validate the technology and determine suitability for commercialisation. This preclinical evaluation, the cost of which will be borne by ValiRx of up to £100,000, will investigate the action of the molecule against Endometrial, Pancreatic and Bile Duct Cancers.

At the conclusion of the evaluation period (December 2022), the Company has an option to license the technology on pre-agreed terms.

Dr Suzy Dilly, CEO of ValiRx commented: "The peptide drug candidate under evaluation in this agreement has been developed for a completely novel cancer target. This cutting-edge technology has potential to enable a first in class drug development programme to be launched in these important therapeutic areas."

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK Domestic Law by virtue of the European Union (Withdrawal) Act 2018 ("UK MAR"). The Directors of the Company take responsibility for this announcement.

More importantly I agree these points are important so I have also posted this again for BOD to see.

Great post by Wallcrawler.

Oh my, this BB has become messier than the carpet in the This Morning dressing room. But, for all the grunts and groans, it seems the majority of shareholders are of one mind on what needs to happen here.

1. Buy/build strategy needs to be paused until the SP is significantly healthier. Absolute must.

2. The bod still have some cash and only need to request moderate headroom for working cap. I will be massively surprised if they ask for even half of the 40-50 million a certain other poster suggests, as it will be end in REJECTION.

3. Invite Hargeaves onto the bod for crying out loud. He’s a businessman, scientist and major SH. It’s a no brainer. If he doesn’t accept, then so be it.

4. The bod need skin in the game. Stella is basically Count Duckula in a blouse. If she ain’t throwing some of those gold coins in at these prices, then she should just leave.

5. Give more explanation about delays. Yes, there are always confidences and commercial sensitivities. I probably deserved the silent treatment at home when I misused my wife’s shoes, but it’s not acceptable here. If VAL can’t convince partners to allow some info, then maybe it’s time to let them go.

Shareholders are clearly very angry and ready to start lining bod up against the wall. But ALL of the above steps are within power of the board and of great mutual benefit. What is frustrating is that the science is ace, but it's some of the business decisions that need to be better. It’s quite high risk ATM, but there are investors waiting in the wings to buy in when this stuff is sorted.

Soon, all of the the really great stuff can be the focus.

They have cash until around 2026 subject to warrants being exercised, deal payments, R and D tax credit refund.

We should be at least 30/40p. CLX is worth at least 20p and can get a deal at any point soon.

Stella did not state we need two years of cash that is a lie. If it is the truth then post the reference and timing of the video otherwise it proves your entire post is misleading.

Yes they can raise about 5 million next year but the only way they can do that is if VAL hits 20, 25p and above. They will not get the allowance at these prices.

We have all these news due so expecting 30,40p at least this year.

Anyway focus on all the news that is due. They need the votes.

A great time to buy and don't forget all this news due soon:

1) Barcelona update due from Feb which will come

2) Hokkaido update from next week

3) Financials showing significant cash reserves

4) Lab contracts- More than one RNS

5) 201 deal/update

6) 301 update

7) World class new compounds coming through for a quick evaluation in our lab. Each one is worth at least 10p moving into SPV and more overtime so huge potential.

8) CLX- significant updates to come.

It was stated before resolution 4 got voted against, shareholder views have expressed so what was planned does not apply unless they say otherwise.

Buy and Build turned to Build then Buy as stated in the last presentation. The SP is less than what it was before. The point is at this price it would be more dilutive so not until at least 20-25p but not here. I think they got the message but they will confirm otherwise they lose votes.

Anyway focus on all the news that is due. They need the votes.

A great time to buy and don't forget all this news due soon:

1) Barcelona update due from Feb which will come

2) Hokkaido update from next week

3) Financials showing significant cash reserves

4) Lab contracts- More than one RNS

5) 201 deal/update

6) 301 update

7) World class new compounds coming through for a quick evaluation in our lab. Each one is worth at least 10p moving into SPV and more overtime so huge potential.

8) CLX- significant updates to come.

Note also that if Suzy states they are currently speaking to big pharmas for CLX the price will rocket fast. Therefore the best price to buy is just below 10p so NOW. Honestly I think 5-10 bagger is likely in the next few months alone let alone longer term.

Lockdown account created 29 June 2022- First post 30 June 2022.

Placing 30 June 2022. All his first posts were AFTER the placing.

Has a history of lies and making up posting history. Complete waster.

So I told him no placing 4 days before but his account was created after the placing. All to discredit for personal agenda.

The 10p placing was in June 2022 not December 2022. Says it all really.

It has no relevance to the current situation.. nobody expected a 10p placing at the time that was a management decision. It dented confidence and destroyed trust which is why we remain far below fair value. Based on asset value and potential we should be at least 30p fact.

Anyway pointless discussion. You need to find someone to talk to rather than stalking me. Your posting history says it all..

Your a retired old man looking for attention. Act your age and grow up.

Besides we all knew the financial situation at the time. Don’t try and twist situations and you popped up after the placings.

In your case I tend to ignore you as your the most worthless poster on here.

I am not the one that is trying to make the company go bust or making it very hard to raise cash by attempting to crash it 24/7 with false placing rumours. If people see that then they should act accordingly not support it. We know who the usual individuals are with the likes of Porky and Lockdowns who trash this company and twist situations. It is down to the company to also act where necessary.

Nothing wrong with a debate regarding management decisions by genuine holders but false placing rumours 24/7 when we have sufficient cash is not on.

I see huge potential with our drugs. We don't want these to go to waste so a higher SP is not just rewarding for shareholders who have backed it but it is great for R and D and our patients as well.

Looking forward to lots of news over the next few weeks and hopefully we will finally get to where we deserve to be.

If anyone should be stepping down it should be Porky. Your performance has been shambolic. DDDD is dead and buried forever, NYCT down to the ground and many others that you were ramping. At least with VAL it can hit 50,100p and more with some correct decisions despite the temporary downside.

Therefore Porky you like to call BOD members to leave due to poor performance but based on your performance you should be the first to stop commenting on boards. In the nicest possible way we don't need financial advice from you based on basic errors from you so please stop.

You can come back when you buy but for now you are fired.

If you were genuine you would not be posting 24/7 because clearly you are not a holder.

You only say that about ramping because you know my points are valid and you don't want people reporting you for the lies. You ignore the facts that we have cash likely until late 2024 so you are assuming we get zero news and zero increase and also given we are undervalued we do not ever rise. Nonsense. As I said we could potentially have at least 8 BIG RNS before then.

The BOD would have known the cash position and were the ones to make the call so it is a bit unfair to make assumptions about people without knowing the facts. Get a life.

Porky pumped DDDD from 80p down to 16p and kept buying all the way down like a spoiled child. The largest shareholder had the sense to sell out. He could read a basic financial report but Porky kept buying thinking it was a bargain and then thought that Oxford FInance would give DDDD 100s millions in loan payments. He listened to what he said and she said rather than reading an RNS and understanding it. How daft. It was not just a wrong call but stupidity on a different level. Clear signs of a COMPLETE NOVICE. NYCT he was shouting £50 but that is now 40p and almost every other stock is always a wrong call with him.

Here he is trying to give us financial advice. What a clown.

Valirx has at least 8 RNS due before the next placing.

1) Barcelona update due from Feb which will come

2) Hokkaido update from next week

3) Financials showing significant cash reserves

4) Lab contracts- More than one RNS

5) 201 deal/update

6) 301 update

7) World class new compounds coming through for a quick evaluation in our lab. Each one is worth at least 10p moving into SPV and more overtime so huge potential.

8) CLX- significant updates to come.

Any one of the above can double us. The market conditions should improve over the next year at some point. All it takes is a few decent buys to move closer to the 20p mark. It appears Valirx has cash until late 2024 and longer with warrants exercised or deal payments.

Key point and call it a freebie but both Kevin and Suzy but have options at 30p/40p and staff also have options around these prices. Suzy and Kevin also have 400/500K shares so I am sure they now need to produce news and time any future placing at the best possible price. I would suggest after lots of news around the 20/25p mark. Doing this at single digits will mean it is unlikely they will reach the target for staff. Therefore staff will not take any future options seriously. They have time.

No real downside from the current SP as CLX is already worth about 20p. All without a lab, evaluation projects, 201, 301. I would say we should be worth 40/50p at the moment so we will rise. Patience required.

THe smart investors would be loading up below 10p knowing the downside is zero over a period of time. I doubt it will ever happen again. This is a huge opportunity to load up.

Would you be happy to buy and know you will likely make at least a 500% return within 12-18 months if all you had to do was wait knowing you had the option to sell at a higher point at any point? Sounds like a plan to me. 10p to 60p not a bad return but personally with a CLX deal i think 100p-200p can be achieved easily.. Be smart DYOR and grab opportunities and avoid listening to losers who will be buying at 50p plus.

Porky any sensible person with money will not listen to you. The fact they have money will often mean they are successful and they will likely go based on evidence and facts. Therefore you are wasting your time.

The last page of the most recent Cenkos report on the bottom of page two confirms cash of 785K at the end of the 2023 year until December. The report gets approved by Suzy.

Val is burning 2-2.5 million per year as an estimate. That takes us around the middle of 2024. Also add in R and D tax refund, revenue, warrants from 14p and a possible deal in the next year but as these are variables I will not include it but people can see we should go beyond that date comfortably.

Most AIM companies end up doing placings near the end in the last 1-2 months. I agree it is better to do it before but it would be news dependent after a number of decent news when the SP can hit a decent level. Besides spend is relatively low so it does not bother me unless it was at or near single digits.

Look at companies like GDR that hardly had any cash left but went from 8p to 50p. They have 1/2 years of cash so once something comes along they can raise a bit at much higher prices.

In future when mentioning from H2 please state whether you mean from the start or the end. Also state a reference or copy and paste the evidence if you state from the start of H2 which is bull. Matters not anyway.

You're not debating your misleading people. How can Valirx have 7 months of cash from here when it clearly stated in the recent Cenkos report they would have 700k by the end of the year?

7 months from now will take us to December. Calculating the cash burn rate it comes closer to the middle of 2024 but you have also ignored warrants, R and D tax refunds, revenue or any potential deal before that time. You are fully aware you are just trying to create fear for your own agenda.

Big difference between a debate and lies.

The concept of "if" holds significance in the stock market as it reflects the conditional nature of investing and decision-making. Investors often consider various "if" scenarios to assess potential risks and rewards before making investment choices.

If we get one or two more SPV from the two now due then we will have two/three preclinical compounds, lab and 201 and various other potential compounds worth significant amounts like 301 or any other new compounds moving into the evaluation stage.

If one advances to later pre-clinical stages as expected then VAL should hit £1 plus with a hint of a deal of IF 201 comes good we will be multiples of what we are.

Only those that don't understand the fundamentals think we will be much lower. The reality is IF we are valued much lower then we can EASILY be taken over with an offer of 50p plus for a takeover or at least much more than the lower current price.

TRX had the better end of the deal and therefore have more to lose in terms of revenue/profit. They have the skills to make it very valuable and to make huge money. We only make a portion of it. Therefore if they play games we pull the deal and they get nothing so no deception.

I think they have gone over this enough times. Lack of data and old patents. At this stage it needs a partner who will play around with it and complete larger trials.

Still getting funding for trials is the most difficult part and if we get the funding and a potential 65 million odd if it goes all the way plus huge royalty payments then it will add huge value at this SP if it is gets done.

What is needed is some indication that progress is being made. All this talk about AZ etc is pointless at this stage until larger trials are done and patents are sorted.

Yeah you held enough shares before but the problem is it went into DDDD so it has all gone now. The 200k would be a significant amount to you now and if you sold now and purchased at 5p you could donate £20k to charity and help 100s of children in third world countries. The problem is though you will not do that because you know VAL has huge potential and can easily hit 20/30p.

No evidence of any real investment anywhere apart from negative comments on a number of stocks. You used to be an active investor who invested in many stocks. It feels like you lost it all.

That's life.

Porky, I don't have time to read all that. I read the first three lines lol. If anyone spins anything it's you going on about placings everyday for the last 2 years when you ignore any news that is due and ignore the low cash burn rate compared to the likes of DDDD burning 55 million odd a year with no revenue.

The 201 situation was not a spin. Look back at the deadlines for 201 and work it out yourself. PYC were due payment in the last financial year based on the deadlines. FACT.

The fact is and we all know you spend all your time here because you want to buy but yet you will not sell your imaginary 200 k shares and buy lower because if you do hold that you know it is more likely the SP will go up.

Exactly and you expect that from Nomlungo and Porky both post to discredit anyone making any valid points because one is wanting to buy cheaper and the other hates the company because he has lost money in the past.

You only need to check the posting history of these two individuals.

Besides Suzy stated in the last presentation 201 was expected this year so far as I recall so nothing has changed. Significant progress must have been made if those on the inside seem to share the same opinion.

The contract with VAL is still ongoing.

As far as I know TRX will generate data in the lab and will be dealing with formulations/patents as part of the application. The work on the science would be ongoing and PYC will likely be assisting with the data modelling as and when needed.

The 201 deal was expected last year so it would have been part of the calculations for revenue that was expected for the last financial year. If not then I see no reason to withhold who the partner was?

The small difference in the amount stated would likely be the difference between the pound to dollar rates when calculated last year.

Just my view it all adds up but down to others to determine the link.